Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the edwards valve or the CoreValve

Yusuke Watanabe, Kentaro Hayashida, Masanori Yamamoto, Gauthier Mouillet, Bernard Chevalier, Atsushi Oguri, Jean Luc Dubois-Rande, Marie Claude Morice, Emmanuel Teiger, Thierry Lefèvre

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The aim of this study was to compare the outcomes of transcatheter aortic valve implantation using the Edwards SAPIEN valve and the Medtronic CoreValve in patients with annulus of intermediate size (20 to 25 mm). From October 2008 to April 2012, 662 consecutive patients who underwent transcatheter aortic valve implantation were studied at 2 French centers. After propensity score matching, a total of 192 patients with intermediate-sized aortic annulus who had received either Edwards (n = 96, mean age 82.4 ± 7.9 years, 48% men, 61.9% receiving the 26-mm valve) or CoreValve (n = 96, mean age 82.5 ± 7.7 years, 50% men, 64.6% receiving the 29-mm valve) prostheses through the transfemoral approach were studied. Adequate reduction in postprocedural mean pressure gradients was achieved with the Edwards valve and the CoreValve (10.9 ± 4.7 vs 9.1 ± 4.4 mm Hg, respectively, p <0.01). Major vascular complications (5.2% vs 3.1%, p = 0.36), device success (95.8% vs 93.8%, p = 0.52), and 30-day survival (90.6% vs 89.6%, p = 0.81) were similar. The incidence of postprocedural aortic regurgitation grade ≥2/4 and new pacemaker implantation was more frequent in the CoreValve group (14.3% vs 35.5%, p <0.01, and 4.2% vs 18.8%, p <0.01, respectively). There was no significant difference in 1-year cumulative survival rates in the Edwards valve group compared with the CoreValve group (80.1 ± 4.2% vs 75.6 ± 4.9%, log-rank p = 0.31). In conclusion, in patients with annulus of intermediate size, similar device success and short-term and midterm outcomes were achieved with either of the valves, irrespective of the specific complications related to each valve.

Original languageEnglish
Pages (from-to)707-713
Number of pages7
JournalAmerican Journal of Cardiology
Volume112
Issue number5
DOIs
Publication statusPublished - 2013 Sep 1
Externally publishedYes

Fingerprint

Aortic Valve
Equipment and Supplies
Propensity Score
Aortic Valve Insufficiency
Prostheses and Implants
Blood Vessels
Survival Rate
Pressure
Survival
Incidence
Transcatheter Aortic Valve Replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the edwards valve or the CoreValve. / Watanabe, Yusuke; Hayashida, Kentaro; Yamamoto, Masanori; Mouillet, Gauthier; Chevalier, Bernard; Oguri, Atsushi; Dubois-Rande, Jean Luc; Morice, Marie Claude; Teiger, Emmanuel; Lefèvre, Thierry.

In: American Journal of Cardiology, Vol. 112, No. 5, 01.09.2013, p. 707-713.

Research output: Contribution to journalArticle

Watanabe, Y, Hayashida, K, Yamamoto, M, Mouillet, G, Chevalier, B, Oguri, A, Dubois-Rande, JL, Morice, MC, Teiger, E & Lefèvre, T 2013, 'Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the edwards valve or the CoreValve', American Journal of Cardiology, vol. 112, no. 5, pp. 707-713. https://doi.org/10.1016/j.amjcard.2013.04.045
Watanabe, Yusuke ; Hayashida, Kentaro ; Yamamoto, Masanori ; Mouillet, Gauthier ; Chevalier, Bernard ; Oguri, Atsushi ; Dubois-Rande, Jean Luc ; Morice, Marie Claude ; Teiger, Emmanuel ; Lefèvre, Thierry. / Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the edwards valve or the CoreValve. In: American Journal of Cardiology. 2013 ; Vol. 112, No. 5. pp. 707-713.
@article{1e324ac7e49240e6a04ad2723a570865,
title = "Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the edwards valve or the CoreValve",
abstract = "The aim of this study was to compare the outcomes of transcatheter aortic valve implantation using the Edwards SAPIEN valve and the Medtronic CoreValve in patients with annulus of intermediate size (20 to 25 mm). From October 2008 to April 2012, 662 consecutive patients who underwent transcatheter aortic valve implantation were studied at 2 French centers. After propensity score matching, a total of 192 patients with intermediate-sized aortic annulus who had received either Edwards (n = 96, mean age 82.4 ± 7.9 years, 48{\%} men, 61.9{\%} receiving the 26-mm valve) or CoreValve (n = 96, mean age 82.5 ± 7.7 years, 50{\%} men, 64.6{\%} receiving the 29-mm valve) prostheses through the transfemoral approach were studied. Adequate reduction in postprocedural mean pressure gradients was achieved with the Edwards valve and the CoreValve (10.9 ± 4.7 vs 9.1 ± 4.4 mm Hg, respectively, p <0.01). Major vascular complications (5.2{\%} vs 3.1{\%}, p = 0.36), device success (95.8{\%} vs 93.8{\%}, p = 0.52), and 30-day survival (90.6{\%} vs 89.6{\%}, p = 0.81) were similar. The incidence of postprocedural aortic regurgitation grade ≥2/4 and new pacemaker implantation was more frequent in the CoreValve group (14.3{\%} vs 35.5{\%}, p <0.01, and 4.2{\%} vs 18.8{\%}, p <0.01, respectively). There was no significant difference in 1-year cumulative survival rates in the Edwards valve group compared with the CoreValve group (80.1 ± 4.2{\%} vs 75.6 ± 4.9{\%}, log-rank p = 0.31). In conclusion, in patients with annulus of intermediate size, similar device success and short-term and midterm outcomes were achieved with either of the valves, irrespective of the specific complications related to each valve.",
author = "Yusuke Watanabe and Kentaro Hayashida and Masanori Yamamoto and Gauthier Mouillet and Bernard Chevalier and Atsushi Oguri and Dubois-Rande, {Jean Luc} and Morice, {Marie Claude} and Emmanuel Teiger and Thierry Lef{\`e}vre",
year = "2013",
month = "9",
day = "1",
doi = "10.1016/j.amjcard.2013.04.045",
language = "English",
volume = "112",
pages = "707--713",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the edwards valve or the CoreValve

AU - Watanabe, Yusuke

AU - Hayashida, Kentaro

AU - Yamamoto, Masanori

AU - Mouillet, Gauthier

AU - Chevalier, Bernard

AU - Oguri, Atsushi

AU - Dubois-Rande, Jean Luc

AU - Morice, Marie Claude

AU - Teiger, Emmanuel

AU - Lefèvre, Thierry

PY - 2013/9/1

Y1 - 2013/9/1

N2 - The aim of this study was to compare the outcomes of transcatheter aortic valve implantation using the Edwards SAPIEN valve and the Medtronic CoreValve in patients with annulus of intermediate size (20 to 25 mm). From October 2008 to April 2012, 662 consecutive patients who underwent transcatheter aortic valve implantation were studied at 2 French centers. After propensity score matching, a total of 192 patients with intermediate-sized aortic annulus who had received either Edwards (n = 96, mean age 82.4 ± 7.9 years, 48% men, 61.9% receiving the 26-mm valve) or CoreValve (n = 96, mean age 82.5 ± 7.7 years, 50% men, 64.6% receiving the 29-mm valve) prostheses through the transfemoral approach were studied. Adequate reduction in postprocedural mean pressure gradients was achieved with the Edwards valve and the CoreValve (10.9 ± 4.7 vs 9.1 ± 4.4 mm Hg, respectively, p <0.01). Major vascular complications (5.2% vs 3.1%, p = 0.36), device success (95.8% vs 93.8%, p = 0.52), and 30-day survival (90.6% vs 89.6%, p = 0.81) were similar. The incidence of postprocedural aortic regurgitation grade ≥2/4 and new pacemaker implantation was more frequent in the CoreValve group (14.3% vs 35.5%, p <0.01, and 4.2% vs 18.8%, p <0.01, respectively). There was no significant difference in 1-year cumulative survival rates in the Edwards valve group compared with the CoreValve group (80.1 ± 4.2% vs 75.6 ± 4.9%, log-rank p = 0.31). In conclusion, in patients with annulus of intermediate size, similar device success and short-term and midterm outcomes were achieved with either of the valves, irrespective of the specific complications related to each valve.

AB - The aim of this study was to compare the outcomes of transcatheter aortic valve implantation using the Edwards SAPIEN valve and the Medtronic CoreValve in patients with annulus of intermediate size (20 to 25 mm). From October 2008 to April 2012, 662 consecutive patients who underwent transcatheter aortic valve implantation were studied at 2 French centers. After propensity score matching, a total of 192 patients with intermediate-sized aortic annulus who had received either Edwards (n = 96, mean age 82.4 ± 7.9 years, 48% men, 61.9% receiving the 26-mm valve) or CoreValve (n = 96, mean age 82.5 ± 7.7 years, 50% men, 64.6% receiving the 29-mm valve) prostheses through the transfemoral approach were studied. Adequate reduction in postprocedural mean pressure gradients was achieved with the Edwards valve and the CoreValve (10.9 ± 4.7 vs 9.1 ± 4.4 mm Hg, respectively, p <0.01). Major vascular complications (5.2% vs 3.1%, p = 0.36), device success (95.8% vs 93.8%, p = 0.52), and 30-day survival (90.6% vs 89.6%, p = 0.81) were similar. The incidence of postprocedural aortic regurgitation grade ≥2/4 and new pacemaker implantation was more frequent in the CoreValve group (14.3% vs 35.5%, p <0.01, and 4.2% vs 18.8%, p <0.01, respectively). There was no significant difference in 1-year cumulative survival rates in the Edwards valve group compared with the CoreValve group (80.1 ± 4.2% vs 75.6 ± 4.9%, log-rank p = 0.31). In conclusion, in patients with annulus of intermediate size, similar device success and short-term and midterm outcomes were achieved with either of the valves, irrespective of the specific complications related to each valve.

UR - http://www.scopus.com/inward/record.url?scp=84881616573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881616573&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2013.04.045

DO - 10.1016/j.amjcard.2013.04.045

M3 - Article

VL - 112

SP - 707

EP - 713

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -